Literature DB >> 31852770

Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology.

Myrtle J van der Wel1, Helen G Coleman2, Jacques J G H M Bergman3, Marnix Jansen4, Sybren L Meijer5.   

Abstract

OBJECTIVE: Guidelines mandate expert pathology review of Barrett's oesophagus (BO) biopsies that reveal dysplasia, but there are no evidence-based standards to corroborate expert reviewer status. We investigated BO concordance rates and pathologist features predictive of diagnostic discordance.
DESIGN: Pathologists (n=51) from over 20 countries assessed 55 digitised BO biopsies from across the diagnostic spectrum, before and after viewing matched p53 labelling. Extensive demographic and clinical experience data were obtained via online questionnaire. Reference diagnoses were obtained from a review panel (n=4) of experienced Barrett's pathologists.
RESULTS: We recorded over 6000 case diagnoses with matched demographic data. Of 2805 H&E diagnoses, we found excellent concordance (>70%) for non-dysplastic BO and high-grade dysplasia, and intermediate concordance for low-grade dysplasia (42%) and indefinite for dysplasia (23%). Major diagnostic errors were found in 248 diagnoses (8.8%), which reduced to 232 (8.3%) after viewing p53 labelled slides. Demographic variables correlating with diagnostic proficiency were analysed in multivariate analysis, which revealed that at least 5 years of professional experience was protective against major diagnostic error for H&E slide review (OR 0.48, 95% CI 0.31 to 0.74). Working in a non-teaching hospital was associated with increased odds of major diagnostic error (OR 1.76, 95% CI 1.15 to 2.69); however, this was neutralised when pathologists viewed p53 labelled slides. Notably, neither case volume nor self-identifying as an expert predicted diagnostic proficiency. Extrapolating our data to real-world case prevalence suggests that 92.3% of major diagnostic errors are due to overinterpreting non-dysplastic BO.
CONCLUSION: Our data provide evidence-based criteria for diagnostic proficiency in Barrett's histopathology. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  barrett's oesophagus; dysplasia; health service research; oesophageal cancer

Mesh:

Year:  2019        PMID: 31852770     DOI: 10.1136/gutjnl-2019-318985

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

Review 1.  Endoscopic Management of Barrett's Esophagus.

Authors:  Jennifer M Kolb; Sachin Wani
Journal:  Dig Dis Sci       Date:  2022-02-28       Impact factor: 3.199

Review 2.  Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.

Authors:  Nicola F Frei; Matthew D Stachler
Journal:  Visc Med       Date:  2022-02-02

3.  Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population.

Authors:  Theresa H Nguyen; Aaron P Thrift; Rollin George; Daniel G Rosen; Hashem B El-Serag; Gyanprakash A Ketwaroo
Journal:  Clin Gastroenterol Hepatol       Date:  2021-04-08       Impact factor: 11.382

4.  Stain-free identification of tissue pathology using a generative adversarial network to infer nanomechanical signatures.

Authors:  Lydia Neary-Zajiczek; Clara Essmann; Anita Rau; Sophia Bano; Neil Clancy; Marnix Jansen; Lauren Heptinstall; Elena Miranda; Amir Gander; Vijay Pawar; Delmiro Fernandez-Reyes; Michael Shaw; Brian Davidson; Danail Stoyanov
Journal:  Nanoscale Adv       Date:  2021-09-02

5.  The natural history of low-grade dysplasia in Barrett's esophagus and risk factors for progression.

Authors:  Mohamed Hussein; Vinay Sehgal; Sarmed Sami; Paul Bassett; Rami Sweis; David Graham; Andrea Telese; Danielle Morris; Manuel Rodriguez-Justo; Marnix Jansen; Marco Novelli; Matthew Banks; Laurence B Lovat; Rehan Haidry
Journal:  JGH Open       Date:  2021-08-06

6.  Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity.

Authors:  A C Katz-Summercorn; S Jammula; A Frangou; I Peneva; M O'Donovan; M Tripathi; S Malhotra; M di Pietro; S Abbas; G Devonshire; W Januszewicz; A Blasko; K Nowicki-Osuch; S MacRae; A Northrop; A M Redmond; D C Wedge; R C Fitzgerald
Journal:  Nat Commun       Date:  2022-03-17       Impact factor: 17.694

7.  Molecular characterization of Barrett's esophagus at single-cell resolution.

Authors:  Georg A Busslinger; Buys de Barbanson; Rurika Oka; Bas L A Weusten; Michiel de Maat; Richard van Hillegersberg; Lodewijk A A Brosens; Ruben van Boxtel; Alexander van Oudenaarden; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

8.  Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study.

Authors:  Andreas V Hadjinicolaou; Sanne N van Munster; Achilleas Achilleos; Jose Santiago Garcia; Sarah Killcoyne; Krish Ragunath; Jacques J G H M Bergman; Rebecca C Fitzgerald; Massimiliano di Pietro
Journal:  EBioMedicine       Date:  2020-05-24       Impact factor: 8.143

Review 9.  Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction.

Authors:  Federica Grillo; Luca Mastracci; Luca Saragoni; Alessandro Vanoli; Francesco Limarzi; Irene Gullo; Jacopo Ferro; Michele Paudice; Paola Parente; Matteo Fassan
Journal:  Pathologica       Date:  2020-09

Review 10.  Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.

Authors:  Ksenia S Maslyonkina; Alexandra K Konyukova; Darya Y Alexeeva; Mikhail Y Sinelnikov; Liudmila M Mikhaleva
Journal:  Cancer Med       Date:  2021-12-06       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.